CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Cardiac Resynchronization Therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01832493
NCT01832493N/ACompleted
CompareCT.gov

Sensor Optimization of CRT Response

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Apr 16, 2013·Updated Aug 29, 2016

In Brief

A clinical study evaluating Cardiac Resynchronization Therapy for Heart Failure. Completed, enrolled 50 participants across 9 sites in 4 countries.

Detailed Summary

The Sensor Optimization of Cardiac Resynchronization Therapy (CRT) Response (SOCR) Study is a multicenter, prospective, non-randomized acute feasibility study that is being conducted to determine if subcutaneous heart sounds and/or intracardiac impedance can acutely identify the optimal atrioventricular (AV) pacing intervals and optimal left ventricular (LV) electrodes in patients indicated for cardiac resynchronization therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesCanada, Hong Kong, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 16, 2013
Enrollment StartJul 1, 2013
Primary CompletionJan 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 13.2 years ago

Interventions

Cardiac Resynchronization Therapydevice

All study patients were evaluated for the optimal atrial-ventricular (AV) programmed interval using various methods.